• Tigecycline: Glycylcycline Antibiotic for Multidrug-Resistan

  2026-05-05

  Tigecycline from APExBIO offers robust activity against multidrug-resistant bacteria, enabling advanced experimental workflows in resistance research. This article details stepwise protocols, troubleshooting strategies, and the translational significance of recent findings in carbapenem-resistant Enterobacter cloacae for optimizing antimicrobial assays.

• Sisomicin vs. Tobramycin: In Vitro Activity Against Clinical

  2026-05-05

  The referenced study systematically compared the in vitro activity of the aminoglycoside antibiotic sisomicin to gentamicin and tobramycin across a broad panel of clinical Gram-negative and Gram-positive isolates. The findings highlight nuanced differences in efficacy and resistance patterns, informing both antibiotic selection and resistance research strategies.

• IWP-2: Wnt Production Inhibitor for Cancer & Pathway Assays

  2026-05-04

  IWP-2, a potent Wnt production inhibitor from APExBIO, empowers researchers to dissect the Wnt/β-catenin pathway with high specificity and reproducibility. This article delivers practical protocols, troubleshooting tips, and translational insights for leveraging IWP-2 in advanced cancer research and functional genomics.

• D-Lin-MC3-DMA: Ionizable Cationic Liposome for RNA Therapeut

  2026-05-04

  D-Lin-MC3-DMA is a benchmark ionizable cationic liposome lipid, enabling efficient siRNA and mRNA delivery via lipid nanoparticles. Its potency for hepatic gene silencing and endosomal escape is well-documented, with orders-of-magnitude increased efficacy over earlier lipids. This article details mechanistic insight, evidence, and integration protocols for RNA delivery.

• Genistein in Action: Protocols and Troubleshooting for Cance

  2026-05-03

  Harnessing the selective tyrosine kinase inhibition of Genistein empowers researchers to dissect oncogenic signaling and cytoskeleton-driven autophagy with precision. This guide delivers practical protocols, troubleshooting insights, and strategic advantages for maximizing Genistein’s impact in cancer biology workflows.

• Dicloxacillin Efficacy Against S. aureus: Intra- and Extrace

  2026-05-02

  This article analyzes the comprehensive evaluation of dicloxacillin's intra- and extracellular activities against Staphylococcus aureus in both in vitro macrophage and in vivo mouse peritonitis models. The findings highlight the importance of pharmacokinetic/pharmacodynamic (PK/PD) indices—especially fTMIC—in predicting antibiotic efficacy, and offer a framework for optimizing antibacterial testing protocols in persistent staphylococcal infection research.

• Structural Basis of TRPM3 Regulation by Neurosteroids and Dr

  2026-05-01

  This study elucidates the molecular mechanisms by which neurosteroids and anticonvulsants modulate the TRPM3 ion channel, a key player in pain perception and neurodevelopmental disorders. High-resolution cryo-EM structures reveal ligand binding sites and inform targeted therapeutic strategies.

• Estradiol Modulates ER Stress to Restore CD4+ T Cell Functio

  2026-05-01

  This study reveals that 17β-estradiol (E2) normalizes splenic CD4+ T lymphocyte function after hemorrhagic shock by attenuating endoplasmic reticulum (ER) stress via estrogen receptor-α and GPR30 pathways. It further demonstrates that the N-glycosylation inhibitor tunicamycin acts as a robust ER stress inducer, providing a critical mechanistic control for dissecting the role of ER stress in immune dysfunction.

• GLT-1 Upregulation Mitigates TBI via CB1-CREB Pathway Inhibi

  2026-04-30

  This study demonstrates that upregulating GLT-1 expression in astrocytes protects against neuronal apoptosis and cognitive dysfunction after traumatic brain injury (TBI) by inhibiting the CB1-CREB signaling pathway. The findings clarify a mechanistic link between endocannabinoid signaling, glutamate regulation, and neuroprotection, informing experimental approaches for memory impairment research.

• Trifluoperazine 2HCl: Precision Dopamine D2 Receptor Inhibit

  2026-04-30

  Experience unparalleled control in dopamine receptor signaling and macrophage-based research with Trifluoperazine 2HCl. This guide reveals step-by-step workflow enhancements, advanced use-cases, and troubleshooting strategies, empowering high-sensitivity assays in neuropharmacology and immunology.

• Oridonin Suppresses Inflammation in Esophageal Cancer via TL

  2026-04-29

  This study demonstrates that oridonin significantly attenuates inflammation and tumor progression in a mouse model of esophageal cancer by inhibiting the TLR4/NF-κB/NLRP3 inflammasome pathway. The findings clarify mechanisms at the intersection of chronic inflammation and esophageal carcinogenesis, with practical implications for preclinical anti-inflammatory research.

• AM 281: CB1 Cannabinoid Receptor Antagonist in TBI Research

  2026-04-29

  AM 281, a potent and selective CB1 cannabinoid receptor antagonist, empowers researchers to dissect neuroprotective mechanisms in memory impairment and traumatic brain injury models. Its nanomolar affinity, workflow-validated protocols, and APExBIO's trusted supply chain make AM 281 the preferred tool for precision modulation of the cannabinoid receptor signaling pathway in neuropharmacology.

• Degarelix Acetate: Mechanistic Mastery for Translational Onc

  2026-04-28

  This thought-leadership article examines Degarelix acetate, a potent GnRH receptor antagonist, through the lens of mechanistic pharmacology and translational research strategy. It bridges insights from cutting-edge aggregation studies, competitive positioning, and validated workflows, providing translational researchers with actionable guidance on exploiting Degarelix acetate for hormone-dependent cancer and pituitary hormone regulation. The article uniquely integrates evidence-based protocol recommendations, contextualizes APExBIO’s product advantages, and critically appraises recent advances in peptide developability and experimental reproducibility.

• SERCA Inhibition by BHQ Enhances HSC Mobilization via ER Str

  2026-04-28

  Li et al. (2025) reveal that selective inhibition of SERCA using 2,5-di-tert-butylbenzene-1,4-diol (BHQ) induces mild endoplasmic reticulum stress, facilitating robust hematopoietic stem cell (HSC) mobilization in vivo. Their findings elucidate a CaMKII-STAT3-CXCR4 signaling axis, offering new insights for optimizing stem cell transplantation strategies.

• PPT (Propyl Pyrazole Triol): Precision Tools for Decoding ER

  2026-04-27

  Explore how PPT (Propyl Pyrazole Triol), a potent ERα agonist, enables unprecedented precision in dissecting estrogen receptor signaling. This article delivers a novel, evidence-driven perspective on assay optimization, biomarker discovery, and translational research.

14540 records 1/970 page Next 12345 下5页 Last page